Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase (Q44231224)

1 December 2017

Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase (English)

1 reference

1 December 2017

1 reference

1 reference

2

André Bensadoun

1 reference

1 December 2017

Karin Conde-Knape

1

1 reference

1 December 2017

Joan H Sobel

series ordinal

3

1 reference

1 December 2017

Jeffrey S Cohn

series ordinal

4

1 reference

1 December 2017

Neil S Shachter

series ordinal

5

1 reference

1 December 2017

1 December 2002

1 reference

Journal of Lipid Research

1 December 2017

1 reference

1 December 2017

43

1 reference

1 December 2017

12

1 reference

1 December 2017

2136-2145

1 reference

Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin. Cholesterol acyltransferase

1 December 2017

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Apolipoprotein C-1 inhibits the hydrolysis by phospholipase A2 of phospholipids in liposomes and cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Effect of serum and C-apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Virus proteins that counteract host immune defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Purification and characterization of lipoprotein lipase from pig myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Contrasting patterns of spontaneous aortic disease in young and old rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Uptake of phospholipid-depleted chylomicrons by the perfused rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

G-250A substitution in promoter of hepatic lipase gene is associated with dyslipidemia and insulin resistance in healthy control subjects and in members of families with familial combined hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Hepatic lipase: new insights from genetic and metabolic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

In vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Enrichment of apolipoprotein B-48 in the LDL density class following in vivo inhibition of hepatic lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Uptake of chylomicron remnants and hepatic lipase-treated chylomicrons by a non-transformed murine hepatocyte cell line in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Heparan sulfate proteoglycans participate in hepatic lipaseand apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

Postprandial lipoproteins and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200210-JLR200

10.1194/JLR.M200210-JLR200

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference